Hip injection study halted after just one participant
NCT ID NCT06977568
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 26 times
Summary
This study aimed to test a new way to inject the drug ZILRETTA into the hip joint for people with hip osteoarthritis. Researchers wanted to see if using a different needle size helped deliver the full dose successfully. Only one person took part before the study was stopped, so no meaningful results were obtained.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS OF HIP are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Medical Pain Management Services PLLC
Albany, New York, 12205, United States
Conditions
Explore the condition pages connected to this study.